Finch Therapeutics Group Statistics
Total Valuation
FNCH has a market cap or net worth of $3.73 million. The enterprise value is $8.53 million.
| Market Cap | 3.73M |
| Enterprise Value | 8.53M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
FNCH has 1.61 million shares outstanding. The number of shares has increased by 0.94% in one year.
| Shares Outstanding | 1.61M |
| Shares Change (YoY) | +0.94% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 53.48% |
| Owned by Institutions (%) | 15.02% |
| Float | 792,862 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.94 |
| Forward PS | n/a |
| PB Ratio | 0.15 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 79.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.33, with a Debt / Equity ratio of 1.32.
| Current Ratio | 6.33 |
| Quick Ratio | n/a |
| Debt / Equity | 1.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 50.82 |
Financial Efficiency
Return on equity (ROE) is -273.00% and return on invested capital (ROIC) is -158.19%.
| Return on Equity (ROE) | -273.00% |
| Return on Assets (ROA) | -114.70% |
| Return on Capital (ROIC) | -158.19% |
| Revenue Per Employee | $107,000 |
| Profits Per Employee | -$74.75M |
| Employee Count | 1 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.46M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.97% in the last 52 weeks. The beta is 0.46, so FNCH's price volatility has been lower than the market average.
| Beta (1Y) | 0.46 |
| 52-Week Price Change | -82.97% |
| 50-Day Moving Average | 2.52 |
| 200-Day Moving Average | 4.28 |
| Relative Strength Index (RSI) | 47.57 |
| Average Volume (30 Days) | 45,148 |
Short Selling Information
The latest short interest is 10,600, so 0.66% of the outstanding shares have been sold short.
| Short Interest | 10,600 |
| Short Previous Month | 9,149 |
| Short % of Shares Out | 0.66% |
| Short % of Float | 1.34% |
| Short Ratio (days to cover) | 0.87 |
Income Statement
In the last 12 months, FNCH had revenue of $107,000 and -$74.75 million in losses. Loss per share was -$46.59.
| Revenue | 107,000 |
| Gross Profit | 107,000 |
| Operating Income | -83.86M |
| Pretax Income | -78.22M |
| Net Income | -74.75M |
| EBITDA | -75.60M |
| EBIT | -79.79M |
| Loss Per Share | -$46.59 |
Balance Sheet
The company has $25.12 million in cash and $30.13 million in debt, giving a net cash position of -$5.00 million or -$3.12 per share.
| Cash & Cash Equivalents | 25.12M |
| Total Debt | 30.13M |
| Net Cash | -5.00M |
| Net Cash Per Share | -$3.12 |
| Equity / Book Value | 22.89M |
| Book Value Per Share | 14.25 |
| Working Capital | 21.76M |
Cash Flow
In the last 12 months, operating cash flow was -$31.51 million and capital expenditures $1.33 million, giving a free cash flow of -$30.18 million.
| Operating Cash Flow | -31.51M |
| Capital Expenditures | 1.33M |
| Free Cash Flow | -30.18M |
| FCF Per Share | -$18.81 |
Margins
Gross margin is 100.00%, with operating and profit margins of -78,374.77% and -69,863.55%.
| Gross Margin | 100.00% |
| Operating Margin | -78,374.77% |
| Pretax Margin | -73,098.13% |
| Profit Margin | -69,863.55% |
| EBITDA Margin | -70,656.07% |
| EBIT Margin | -74,565.42% |
| FCF Margin | -28,203.74% |
Dividends & Yields
FNCH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.94% |
| Shareholder Yield | -0.94% |
| Earnings Yield | -2,120.90% |
| FCF Yield | -856.20% |
Analyst Forecast
The average price target for FNCH is $210.00, which is 8,836.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $210.00 |
| Price Target Difference | 8,836.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 12, 2023. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jun 12, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
FNCH has an Altman Z-Score of -13.08 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.08 |
| Piotroski F-Score | 3 |